Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Archives
Print | Email | Share | Comments (0)

A New Buzzword: Researchers Say Inflammation May Predict Type 2 Risk


Nov 1, 2002

In 1999, the first association between markers of inflammation and the subsequent development of type 2 diabetes was reported. Today, researchers are positing a definitive link between the two and suggesting that treatments to reduce inflammation might be a means of preventing or forestalling illness.

What Is Inflammation?

At a press conference during the June 2002 American Diabetes Association Scientific Sessions in San Francisco, California, a panel of researchers began by defining inflammation as the way the body normally responds to injury.

Inflammation is a protective reaction by the body to injury, irritation or infection. The inflammation process occurs, for instance, when you bump your head or scratch your arm. You get swelling and redness because specialized blood cells are sent to the area of injury to destroy and clean up damaged cells.

However, when the immune system malfunctions, the inflammation process itself damages healthy tissue.

An earlier link between inflammation and heart disease was made when doctors found higher levels of inflammation markers in the blood of people with heart disease. They then discovered that such markers could predict a heart attack. Higher levels of those same markers have now been found in people with diabetes and those at risk for diabetes.

What Are the Markers?

One inflammation marker, known as C-reactive protein (CRP), appears to be elevated in the presence of heart disease, diabetes and obesity.

Vivian Fonseca, MD, professor of medicine at Tulane University Health Sciences Center in New Orleans, Louisiana, says: "It is possible that if you have excessive fat, substances secreted from fat stimulate markers of inflammation. So inflammation may be the common link for developing insulin resistance, diabetes and heart disease, making it very attractive to monitor and treat CRP levels."

In data collected from a study funded by the National Institutes of Health, more than 10,000 people who did not have diabetes were followed with blood sampling for nine years. According to Bruce Duncan, MD, PhD, associate professor in the School of Medicine of the Federal University of Rio Grande do Sul, individuals who had high levels of inflammation - especially sialic acid - were at 20 to 60 percent higher risk for developing diabetes than those with lower levels.

"We have here now a study that demonstrates that markers of inflammation can predict the development of diabetes," says Duncan. "The question is no longer 'Does this association exist?' but now 'Why does it exist?' "

In a separate study conducted in Hong Kong, researchers point out that a high CRP level was an "independent predictor" for the development of kidney disease in people with diabetes.

Other inflammation markers include plasminogen activator inhibitor-1 (PAI-1) and nuclear factor kappaB (NfkappaB).

So What Can You Do?

Researchers at Kuwait University in Kuwait found that people with diabetes whose levels of CRP markers were in the highest 20th percentile were four times more likely to suffer from cardiovascular disease than those who measured in the lowest 20th percentile. Nabilla Abdella, MB, CHP, FRCP, professor of medicine at Kuwait University, says people with diabetes who have high levels of CRP markers need to more tightly regulate blood pressure and cholesterol as well as blood glucose.

Paresh Dandona, FRCP, MD, PhD, head of the division of endocrinology, diabetes and metabolism at the State University of New York at Buffalo, suggests that food intake leads to an inflammatory state and that people who are obese are at a constant risk.

Dandona argues that "healthy living" is the best way to keep inflammation markers down.

"I personally think that any attempt to restrict caloric intake in a nation that overconsumes calories by the ton is commendable É If people lose weight, these markers come down dramatically."

However, Dandona acknowledges that losing weight is difficult. That being the case, he recommends the use of drugs to aid in the process.

Thiazolidinediones

Studies have demonstrated that type 2 diabetes drugs in the thiazolidinedione class ("TZDs," or "glitazones"), such as Avandia, have anti-inflammatory benefits.

In a recent study, inflammation markers fell by 20 to 40 percent after six weeks in 11 people who were taking 4 mg per day of rosiglitazone (Avandia), according to Dandona.

"This leads us to speculate that patients treated with [Avandia] might not develop atherosclerosis [narrowing of the arteries] at the high rate usually seen in diabetes," he says, adding that such treatment of those at risk for diabetes might help prevent the disease itself.

Although Avandia's counterpart Actos (pioglitazone) was not used in the study, Dandona predicts that it would have the same effect.

Statins

Statins, which are used to reduce high cholesterol levels, have also been found to reduce inflammation markers.

A study of adults in Saskatchewan with type 2 diabetes found that statin use was associated with a 10-month delay in the need to start insulin treatment, according to Jeffery A. Johnson, PhD, associate professor of public health sciences at the University of Alberta, Canada. He suggests that the anti-inflammatory action of statins might decrease insulin resistance.

Johnson recommends evaluating the potential of statins to delay the onset of diabetes in high-risk individuals.

Clinical adviser's note: Along with the exciting news about the anti-inflammatory properties of the TZDs and the statins, attention has also been rekindled regarding that good old standby aspirin. In addition to aspirin's anti-platelet activity, which makes it useful as a daily preventive therapy for reducing cardiac risk, aspirin's anti-inflammatory effects may reduce cardiac risk even further than the anti-clotting action alone.

Also stay tuned for new guidelines regarding broad testing for CRP, one of many chemicals that increase if inflammation is present. Who should be tested? That is the question that an expert panel is contemplating. The good news is that the CRP test is relatively inexpensive.

- - - - -

Inflammation Marker Associated With Previous Gestational Diabetes Is Linked to Type 2

Increased levels of the inflammation marker total sialic acid (TSA) are associated with previous gestational diabetes, say researchers in the United Kingdom and Brazil.

"Gestational diabetes predicts type 2 diabetes and may be part of this syndrome," write the researchers.

Women who had a history of gestational diabetes were observed against a random sample of 46 women with no history of gestational diabetes. The average TSA was 71.8 mg/dl higher in the women who had previous gestational diabetes. After adjustment for body mass index, fasting insulin sensitivity and number of years spent in school, TSA was 4 mg/dl higher in women who had previous gestational diabetes.

-Diabetes Care, August 2002


Categories: Blood Glucose, Complications & Care, Diabetes, Diabetes, Food, Insulin, Losing weight, Pre-Diabetes, Type 2 Issues



You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.